{
    "nctId": "NCT05315154",
    "briefTitle": "Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer",
    "officialTitle": "Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer Clinically and Ultrasonographically Node-negative",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 800,
    "primaryOutcomeMeasure": "Disease free survival (DFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women\n* Aged 18 years or older\n* Histologically confirmed invasive breast carcinoma (core or open biopsy), independent of hormone receptor and HER2 status\n* Tumor smaller than 5 cm (T1 or T2) in clinical and radiological exams\n* Clinically negative axilla\n* Sonographically negative axilla or negative core biopsy/ fine needle biopsy (FNB) when ultrasound is suspect (lymph node tissue is required in core/FNB sample)\n* Planned breast conservative surgery or mastectomy\n* Written informed consent\n\nExclusion Criteria:\n\n* Previous diagnostic of any invasive neoplasia (excluded skin cancer no melanoma)\n* Metastatic disease in biopsy or image before treatment\n* Withdrawal from participating of the study\n* Initiated treatment for current breast cancer prior to study enrollment\n* Pregnancy\n* Breastfeed",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}